课题基金 / 基金详情

REGULATION OF LIVER FUNCTION BY MAPK/MKP-1

REGULATION OF LIVER FUNCTION BY MAPK/MKP-1
MAPK/MKP-1 对肝功能的调节
批准号:
7424051
负责人:
Anton M Bennett
金额:
$20.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2011-04-30

项目摘要

项目成果

Anton M Bennett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broad goal of this project is to understand the molecular mechanisms that control liver function in health and disease. Specifically, the aim of this project is to understand how local nuclear and cytosolic calcium signals integrate with the mitogen-activated protein kinase (MARK) signal transduction pathway in the control of liver growth, regeneration, and metabolism. The MAPKs are negatively regulated by a family of enzymes known as the MARK phosphatases (MKPs). Recent work from this laboratory has shown that the nuclear localized MKP family member, MKP-1, is essential for the negative regulation of the MAPKs. These observations are supported in vivo where we have discovered that mice lacking expression of MKP-1 exhibit enhanced MAPK activation in the liver which correlates with enhanced hepatic lipid metabolism and resistance to the acquisition of a fatty liver. We present preliminary data to support a new signaling paradigm in which cytosolic and nuclear calcium signals differentially regulate the transcription of MKP-1 in a positive and negative manner, respectively. This discrete regulation of MKP-1 in the nucleus by calcium controls MAPK-mediated gene expression. We hypothesize that local calcium signals regulates MKP-1 expression which serves to limit the magnitude and spatio-temporal kinetics of MAPK-mediated gene activity required for liver growth, regeneration, and metabolic homeostasis. We will test this hypothesis in three specific aims. Aim 1 will define the molecular basis for the differential effects of nuclear and cytosolic calcium on the regulation of MKP-1 gene transcription by disrupting calcium signaling in these sub-cellular compartments using previously developed targeted calcium-binding proteins. Aim 2 will define the importance of MKP-1 nuclear localization for its physiological function in the liver. To test this, a novel genetic mutation in MKP-1 that targets it to the cytosol will be "knocked-in" to mice using an inducible CreLoxP approach. Aim 3 will determine the role of MKP-1 on liver growth, regeneration, and stress management using MKP 1 "knock-out" mice. Together with projects by Nathanson and Ehrlich, the proposed molecular, biochemical and genetic approaches in this project will establish a new signaling paradigm between local calcium signals, MKP-1 and MAPK-mediated gene expression in the control of liver function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MKP5 allostery in MAPK regulation and signaling in the heart
  • 批准号:
    10552036
  • 项目类别:
  • 资助金额:
    $60.48万
  • 财政年份:
    2022
  • 负责人:
    Anton M Bennett
  • 依托单位:
MKP5 allostery in MAPK regulation and signaling in the heart
  • 批准号:
    10375784
  • 项目类别:
  • 资助金额:
    $62.03万
  • 财政年份:
    2022
  • 负责人:
    Anton M Bennett
  • 依托单位:
Dual-specificity phosphatase action in muscle disease
  • 批准号:
    10621754
  • 项目类别:
  • 资助金额:
    $52.93万
  • 财政年份:
    2022
  • 负责人:
    Anton M Bennett
  • 依托单位:
Dual-specificity phosphatase action in muscle disease
  • 批准号:
    10342959
  • 项目类别:
  • 资助金额:
    $52.47万
  • 财政年份:
    2022
  • 负责人:
    Anton M Bennett
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: